OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Enhancing these processes involves modifying various parameters, including cell line engineering, media formulation, and bioreactor conditions. A key goal is to maximize antibody titer while reducing production financ